Tackling Therapeutic Resistance in Cancer

Cancer is a dynamic and evolving disease shaped by complex genetic and molecular alterations that influence treatment response and clinical outcomes. Our laboratory is focused on advancing precision oncology for patients with advanced and metastatic cancers through research spanning molecular mechanisms of therapeutic sensitivity and resistance, biomarker discovery, drug development, and liquid biopsy technologies. We investigate the biological processes that drive cancer progression and treatment failure while developing innovative strategies to better match patients with the therapies most likely to benefit them. By bridging fundamental cancer biology with translational and clinical research, we aim to accelerate the development of more personalized, effective, and durable treatment approaches that improve the lives of patients living with cancer.